A citation-based method for searching scientific literature

G P H Gui, G Kadayaprath, N Darhouse, J Self, A Ward, R A'Hern, R Eeles. Eur J Surg Oncol 2006
Times Cited: 8







List of co-cited articles
34 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Screening younger women with a family history of breast cancer--does early detection improve outcome?
A Maurice, D G R Evans, A Shenton, L Ashcroft, A Baildam, L Barr, G Byrne, N Bundred, C Boggis, M Wilson,[...]. Eur J Cancer 2006
33
62

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach, C R M Boggis, A K Dixon, D F Easton, R A Eeles, D G R Evans, F J Gilbert, I Griebsch, R J C Hoff, P Kessar,[...]. Lancet 2005
698
50

Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience.
Laura Cortesi, Daniela Turchetti, Isabella Marchi, Antonella Fracca, Barbara Canossi, Battista Rachele, Ruscelli Silvia, Pecchi Anna Rita, Torricelli Pietro, Federico Massimo. BMC Cancer 2006
41
50


Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
Christiane K Kuhl, Simone Schrading, Claudia C Leutner, Nuschin Morakkabati-Spitz, Eva Wardelmann, Rolf Fimmers, Walther Kuhn, Hans H Schild. J Clin Oncol 2005
644
37

Screening women aged less than 50 years with a family history of breast cancer.
J Kollias, D M Sibbering, R W Blamey, P A Holland, Z Obuszko, A R Wilson, A J Evans, I O Ellis, C W Elston. Eur J Cancer 1998
48
37


The psychological impact of mammographic screening. A systematic review.
J Brett, C Bankhead, B Henderson, E Watson, J Austoker. Psychooncology 2005
183
37

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
25

Hereditary breast cancer growth rates and its impact on screening policy.
Madeleine M A Tilanus-Linthorst, Mieke Kriege, Carla Boetes, Wim C J Hop, Inge-Marie Obdeijn, Jan C Oosterwijk, Hans L Peterse, Harmine M Zonderland, Sybren Meijer, Alexander M M Eggermont,[...]. Eur J Cancer 2005
49
25

Earlier detection of breast cancer by surveillance of women at familial risk.
M M Tilanus-Linthorst, C C Bartels, A I Obdeijn, M Oudkerk. Eur J Cancer 2000
64
25

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Mieke Kriege, Cecile T M Brekelmans, Carla Boetes, Peter E Besnard, Harmine M Zonderland, Inge Marie Obdeijn, Radu A Manoliu, Theo Kok, Hans Peterse, Madeleine M A Tilanus-Linthorst,[...]. N Engl J Med 2004
25


Diagnostic performance of digital versus film mammography for breast-cancer screening.
Etta D Pisano, Constantine Gatsonis, Edward Hendrick, Martin Yaffe, Janet K Baum, Suddhasatta Acharyya, Emily F Conant, Laurie L Fajardo, Lawrence Bassett, Carl D'Orsi,[...]. N Engl J Med 2005
25

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Ellen Warner, Donald B Plewes, Kimberley A Hill, Petrina A Causer, Judit T Zubovits, Roberta A Jong, Margaret R Cutrara, Gerrit DeBoer, Martin J Yaffe, Sandra J Messner,[...]. JAMA 2004
762
25

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.
C T Brekelmans, C Seynaeve, C C Bartels, M M Tilanus-Linthorst, E J Meijers-Heijboer, C M Crepin, A A van Geel, M Menke, L C Verhoog, A van den Ouweland,[...]. J Clin Oncol 2001
225
25

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. JAMA 2006
25

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.
Mark E Robson, Pierre O Chappuis, Jaya Satagopan, Nora Wong, Jeff Boyd, John R Goffin, Clifford Hudis, David Roberge, Larry Norton, Louis R Bégin,[...]. Breast Cancer Res 2004
210
25

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Sylvia K Plevritis, Allison W Kurian, Bronislava M Sigal, Bruce L Daniel, Debra M Ikeda, Frank E Stockdale, Alan M Garber. JAMA 2006
179
25

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.
I Griebsch, J Brown, C Boggis, A Dixon, M Dixon, D Easton, R Eeles, D G Evans, F J Gilbert, J Hawnaur,[...]. Br J Cancer 2006
81
25

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
25


Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group.
P Møller, M M Reis, G Evans, H Vasen, N Haites, E Anderson, C M Steel, J Apold, F Lalloo, L Maehle,[...]. Dis Markers 1999
29
25

Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.
Francesco Sardanelli, Franca Podo, Giuliano D'Agnolo, Arduino Verdecchia, Mariano Santaquilani, Renato Musumeci, Giovanna Trecate, Siranoush Manoukian, Sandro Morassut, Clelia de Giacomi,[...]. Radiology 2007
243
25

Screening by mammography, women with a family history of breast cancer.
F Lalloo, C R Boggis, D G Evans, A Shenton, A G Threlfall, A Howell. Eur J Cancer 1998
69
25

Performance of screening mammography among women with and without a first-degree relative with breast cancer.
K Kerlikowske, P A Carney, B Geller, M T Mandelson, S H Taplin, K Malvin, V Ernster, N Urban, G Cutter, R Rosenberg,[...]. Ann Intern Med 2000
147
25

Common hereditary cancers and implications for primary care.
J Emery, A Lucassen, M Murphy. Lancet 2001
48
25

Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.
Sue M Moss, Howard Cuckle, Andy Evans, Louise Johns, Michael Waller, Lynda Bobrow. Lancet 2006
315
25

The psychological impact of mammographic screening on women with a family history of breast cancer--a systematic review.
Eila K Watson, Bethan J Henderson, Joanne Brett, Clare Bankhead, Joan Austoker. Psychooncology 2005
41
25

Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis.
Valerie A McCormack, Isabel dos Santos Silva. Cancer Epidemiol Biomarkers Prev 2006
25

Family history and the risk of breast cancer: a systematic review and meta-analysis.
P D Pharoah, N E Day, S Duffy, D F Easton, B A Ponder. Int J Cancer 1997
382
25

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Mieke Kriege, Cecile T M Brekelmans, Carla Boetes, Sara H Muller, Harmine M Zonderland, Inge Marie Obdeijn, Radu A Manoliu, Theo Kok, Emiel J T Rutgers, Harry J de Koning,[...]. Cancer 2006
56
25

Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer.
Rita K Schmutzler, Kerstin Rhiem, Petra Breuer, Eva Wardelmann, Martin Lehnert, Silke Coburger, Barbara Wappenschmidt. Eur J Cancer Prev 2006
23
25

MRI in the early detection of breast cancer in women with high genetic risk.
Giovanna Trecate, Daniele Vergnaghi, Siranuosh Manoukian, Silvana Bergonzi, Gianfranco Scaperrotta, Monica Marchesini, Claudio Ferranti, Bernard Peissel, Gianbattista Spatti, Silvia Bohm,[...]. Tumori 2006
30
25


Contribution of clinical breast examination to mammography screening in the early detection of breast cancer.
C Bancej, K Decker, A Chiarelli, M Harrison, D Turner, J Brisson. J Med Screen 2003
43
12

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
John R McLaughlin, Harvey A Risch, Jan Lubinski, Pal Moller, Parviz Ghadirian, Henry Lynch, Beth Karlan, David Fishman, Barry Rosen, Susan L Neuhausen,[...]. Lancet Oncol 2007
140
12

The "duty to warn" a patient's family members about hereditary disease risks.
Kenneth Offit, Elizabeth Groeger, Sam Turner, Eve A Wadsworth, Mary A Weiser. JAMA 2004
154
12

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
665
12


Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.
S A Narod, H Risch, R Moslehi, A Dørum, S Neuhausen, H Olsson, D Provencher, P Radice, G Evans, S Bishop,[...]. N Engl J Med 1998
384
12


Factors contributing to mammography failure in women aged 40-49 years.
Diana S M Buist, Peggy L Porter, Constance Lehman, Stephen H Taplin, Emily White. J Natl Cancer Inst 2004
207
12

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
706
12

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
Jacek Gronwald, Nadine Tung, William D Foulkes, Kenneth Offit, Ruth Gershoni, Mary Daly, Charmaine Kim-Sing, Hakan Olsson, Peter Ainsworth, Andrea Eisen,[...]. Int J Cancer 2006
177
12

BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.
Robert W Haile, Duncan C Thomas, Valerie McGuire, Anna Felberg, Esther M John, Roger L Milne, John L Hopper, Mark A Jenkins, A Joan Levine, Mary M Daly,[...]. Cancer Epidemiol Biomarkers Prev 2006
68
12

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006
394
12

Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Gillian Mitchell, Antonis C Antoniou, Ruth Warren, Susan Peock, Judith Brown, Russell Davies, Jenny Mattison, Margaret Cook, Iqbal Warsi, D Gareth Evans,[...]. Cancer Res 2006
90
12

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Susan M Domchek, Tara M Friebel, Susan L Neuhausen, Theresa Wagner, Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Lancet Oncol 2006
211
12

Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee.
F Eisinger, N Alby, A Bremond, J Dauplat, M Espié, P Janiaud, F Kuttenn, J P Lebrun, J P Lefranc, J Pierret,[...]. Ann Oncol 1998
104
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.